- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.74 Å
- Oligo State
- homo-trimer
- Ligands
- 3 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 6 x NHE: 2-[N-CYCLOHEXYLAMINO]ETHANE SULFONIC ACID(Non-covalent)
NHE.2: 9 residues within 4Å:- Chain A: F.137, G.139, F.140, Q.354, F.488
- Chain C: F.140
- Ligands: SO4.4, NHE.13, NHE.24
8 PLIP interactions:6 interactions with chain A, 2 interactions with chain C- Hydrophobic interactions: A:F.137, A:F.140, A:F.488, C:F.140, C:F.140
- Hydrogen bonds: A:G.139, A:F.140, A:Q.354
NHE.3: 9 residues within 4Å:- Chain A: F.387, F.477, Y.478, D.479, V.482, N.496, I.499, L.503
- Ligands: NAG.1
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:F.387, A:F.477, A:Y.478
- Hydrogen bonds: A:D.479
NHE.13: 9 residues within 4Å:- Chain A: F.140
- Chain B: F.137, G.139, F.140, Q.354, F.488
- Ligands: NHE.2, SO4.15, NHE.24
8 PLIP interactions:6 interactions with chain B, 2 interactions with chain A- Hydrophobic interactions: B:F.137, B:F.140, B:F.488, A:F.140, A:F.140
- Hydrogen bonds: B:G.139, B:F.140, B:Q.354
NHE.14: 9 residues within 4Å:- Chain B: F.387, F.477, Y.478, D.479, V.482, N.496, I.499, L.503
- Ligands: NAG.12
4 PLIP interactions:4 interactions with chain B- Hydrophobic interactions: B:F.387, B:F.477, B:Y.478
- Hydrogen bonds: B:D.479
NHE.24: 9 residues within 4Å:- Chain B: F.140
- Chain C: F.137, G.139, F.140, Q.354, F.488
- Ligands: NHE.2, NHE.13, SO4.26
8 PLIP interactions:6 interactions with chain C, 2 interactions with chain B- Hydrophobic interactions: C:F.137, C:F.140, C:F.488, B:F.140, B:F.140
- Hydrogen bonds: C:G.139, C:F.140, C:Q.354
NHE.25: 9 residues within 4Å:- Chain C: F.387, F.477, Y.478, D.479, V.482, N.496, I.499, L.503
- Ligands: NAG.23
4 PLIP interactions:4 interactions with chain C- Hydrophobic interactions: C:F.387, C:F.477, C:Y.478
- Hydrogen bonds: C:D.479
- 21 x SO4: SULFATE ION(Non-functional Binders)
SO4.4: 6 residues within 4Å:- Chain A: F.137, R.339, Q.354, E.356
- Chain C: R.106
- Ligands: NHE.2
Ligand excluded by PLIPSO4.5: 4 residues within 4Å:- Chain A: L.273, N.276, N.277, R.364
Ligand excluded by PLIPSO4.6: 3 residues within 4Å:- Chain A: L.193, D.194, K.226
Ligand excluded by PLIPSO4.7: 8 residues within 4Å:- Chain A: R.49, W.52, S.146, A.147, M.370
- Chain B: L.456, Y.457, Y.458
Ligand excluded by PLIPSO4.8: 4 residues within 4Å:- Chain A: N.426, N.428, R.429
- Ligands: SO4.9
Ligand excluded by PLIPSO4.9: 5 residues within 4Å:- Chain A: N.444, K.445, G.446, K.461
- Ligands: SO4.8
Ligand excluded by PLIPSO4.10: 2 residues within 4Å:- Chain A: G.471, E.472
Ligand excluded by PLIPSO4.15: 6 residues within 4Å:- Chain A: R.106
- Chain B: F.137, R.339, Q.354, E.356
- Ligands: NHE.13
Ligand excluded by PLIPSO4.16: 4 residues within 4Å:- Chain B: L.273, N.276, N.277, R.364
Ligand excluded by PLIPSO4.17: 3 residues within 4Å:- Chain B: L.193, D.194, K.226
Ligand excluded by PLIPSO4.18: 8 residues within 4Å:- Chain B: R.49, W.52, S.146, A.147, M.370
- Chain C: L.456, Y.457, Y.458
Ligand excluded by PLIPSO4.19: 4 residues within 4Å:- Chain B: N.426, N.428, R.429
- Ligands: SO4.20
Ligand excluded by PLIPSO4.20: 5 residues within 4Å:- Chain B: N.444, K.445, G.446, K.461
- Ligands: SO4.19
Ligand excluded by PLIPSO4.21: 2 residues within 4Å:- Chain B: G.471, E.472
Ligand excluded by PLIPSO4.26: 6 residues within 4Å:- Chain B: R.106
- Chain C: F.137, R.339, Q.354, E.356
- Ligands: NHE.24
Ligand excluded by PLIPSO4.27: 4 residues within 4Å:- Chain C: L.273, N.276, N.277, R.364
Ligand excluded by PLIPSO4.28: 3 residues within 4Å:- Chain C: L.193, D.194, K.226
Ligand excluded by PLIPSO4.29: 8 residues within 4Å:- Chain A: L.456, Y.457, Y.458
- Chain C: R.49, W.52, S.146, A.147, M.370
Ligand excluded by PLIPSO4.30: 4 residues within 4Å:- Chain C: N.426, N.428, R.429
- Ligands: SO4.31
Ligand excluded by PLIPSO4.31: 5 residues within 4Å:- Chain C: N.444, K.445, G.446, K.461
- Ligands: SO4.30
Ligand excluded by PLIPSO4.32: 2 residues within 4Å:- Chain C: G.471, E.472
Ligand excluded by PLIP- 3 x TAR: D(-)-TARTARIC ACID(Non-covalent)
TAR.11: 5 residues within 4Å:- Chain A: S.443, K.445, G.464, K.465, S.466
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:S.443, A:S.466
TAR.22: 5 residues within 4Å:- Chain B: S.443, K.445, G.464, K.465, S.466
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:S.443, B:S.466
TAR.33: 5 residues within 4Å:- Chain C: S.443, K.445, G.464, K.465, S.466
2 PLIP interactions:2 interactions with chain C- Hydrogen bonds: C:S.443, C:S.466
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Battles, M.B. et al., Structural Basis for Respiratory Syncytial Virus Fusion Inhibitor Resistance. To be published
- Release Date
- 2019-08-07
- Peptides
- Fusion glycoprotein F0: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
FB
FC
F
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.74 Å
- Oligo State
- homo-trimer
- Ligands
- 3 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 6 x NHE: 2-[N-CYCLOHEXYLAMINO]ETHANE SULFONIC ACID(Non-covalent)
- 21 x SO4: SULFATE ION(Non-functional Binders)
- 3 x TAR: D(-)-TARTARIC ACID(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Battles, M.B. et al., Structural Basis for Respiratory Syncytial Virus Fusion Inhibitor Resistance. To be published
- Release Date
- 2019-08-07
- Peptides
- Fusion glycoprotein F0: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
FB
FC
F